New Drug for Alzheimer Disease Shows Promise in Phase 3 Trial

WEDNESDAY, Sept. 28, 2022 (HealthDay) -- Japanese drugmaker Eisai on Wednesday said its experimental drug lecanemab helped slow thinking declines among people in the early stages of Alzheimer disease. The findings from a phase 3 clinical trial have...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news